Company Filing History:
Years Active: 2022
Title: Naser Abdullah Alhumam: Innovator in Antifungal Treatments
Introduction
Naser Abdullah Alhumam is a notable inventor based in Al-Ahsa, Saudi Arabia. He has made significant contributions to the field of medicine, particularly in the treatment of fungal infections. His innovative approach utilizes dabigatran etexilate, a compound traditionally used as an anticoagulant, to combat fungal pathogens.
Latest Patents
Alhumam holds a patent for a method of treating fungal infections using dabigatran etexilate. This method involves administering a therapeutically effective amount of dabigatran etexilate to a subject in need. The patent highlights the potential of dabigatran etexilate as a broad-spectrum antifungal agent, effective against a wide array of fungal pathogens. It can be used to treat both topical and systemic fungal infections, showcasing its versatility in medical applications.
Career Highlights
Naser Abdullah Alhumam is affiliated with King Fahd University of Petroleum and Minerals, where he contributes to research and innovation in the medical field. His work is characterized by a commitment to advancing treatment options for patients suffering from fungal infections.
Collaborations
Alhumam collaborates with esteemed colleagues, including Mahmoud Elsayed and Abdulla Yousef Al-Taher. These partnerships enhance the research and development of innovative medical solutions.
Conclusion
Naser Abdullah Alhumam's work in developing antifungal treatments represents a significant advancement in medical science. His innovative use of dabigatran etexilate opens new avenues for effective treatment options.